Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| ABAGS | ES-US500RMF | |
|---|---|---|
| Only in ABAGS | ||
| Ligand Pharmaceuticals | 2.90% | N/A |
| Q2 | 2.82% | N/A |
| 2.78% | N/A | |
| 2.78% | N/A | |
| Only in ES-US500RMF | ||
| N/A | 8.32% | |
| N/A | 7.32% | |
| N/A | 5.74% | |
| N/A | 5.48% | |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| ES-US500RMF | +6.50% | 12.70% | 0.51 |
| ABAGS | +7.86% | 16.88% | 0.47 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | ABAGS | ES-US500RMF |
|---|---|---|
Fund details | ||
| Fund size | 295 million | 2,837 million |
| Inception date | 3 Nov 2015 | 6 Feb 2013 |
| Master fund | abrdn SICAV I - North American Smaller Companies Fund | กองทุน iShares Core S&P 500 ETF |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 6 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 100.94% | 91.45% |
Minimum purchase and redemption | ||
| First purchase | 1,000 THB | 1 THB |
| Subsequent purchase | 1,000 THB | 1 THB |
| Redemption (amount) | 1,000 THB | 1 THB |
| Redemption (units) | 100 units | 1 units |
| Balance (amount) | No minimum | No minimum |
| Balance (units) | 100 units | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:30 |
| Redeem before | 13:00 | 15:30 |
| Redemption paid | T+5 | T+3 |